• People with diabetes in South Africa can now get started with Dexcom G7
• Dexcom G7 has the fastest sensor warmup on the market, with no finger sticks or scanning required
• Dexcom G7 builds on the unparalleled accuracy of Dexcom CGM1 that is supported by more peer reviewed, clinical research than any other CGM
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available for people with diabetes age two years and older in South Africa– marking the first major milestone in the availability of the revolutionary new technology in Africa.
“The next-generation Dexcom G7 CGM System empowers users and helps simplify diabetes management with our smallest, most intuitive real-time CGM. Bringing our technology to more people around the world continues to be a top priority and we are thrilled that the diabetes community in South Africa will be amongst the first, outside of Europe, to experience the benefits of G7.” said Alex Moussa, Senior Vice President and General Manager EMEA, Dexcom. Together with VitalAire Diabetes, the healthcare affiliate of the French Group Air Liquide in South Africa,
Dexcom will introduce G7 in South Africa with the goal to reach as many people as possible with this life-changing technology.
“Since we started our journey with Dexcom seven years ago, we’ve eliminated over 10 million fingerpricks and helped improve the lives of more than 1,000 people living with diabetes in South Africa. We’re thrilled to begin the South African rollout of the next-generation CGM technology that vastly improves upon the technology available today”, said Imke Erasmus, General Manager VitalAire Diabetes.
Improved patient outcomes and exceptional customer service are at the core of VitalAire Diabetes’ offering, and with the Dexcom G7, VitalAire Diabetes will continue to provide value to both healthcare professionals and patients in South Africa.
“I have been using Dexcom G6 for a year, and within that year, I have managed to lower my HbA1c and improve my overall health. It has empowered me to take the initiative regarding my condition and to empower other people living with diabetes. Dexcom has changed my life for the better. I can now enjoy family time and activities I love without worrying. Dexcom has truly made my journey with diabetes easier, and I have reached a point where I am making the best of it and truly enjoying the journey. I wish more people could get the chance to use
this life-changing technology.” Thapi Semenya, Dexcom user in Limpopo Province.
According to the International Diabetes Federation, diabetes affects approximately 4.5 million people in South Africa, with an estimated 12.8% of the adult population living with the condition. Dexcom G7: The Most Powerful CGM on the Market Dexcom G7 offers a powerful yet simple way to help South African users gain greater control of their diabetes, so they can manage the disease more confidently each day. Its low-profile, all-in-one wearable warms up faster than any other CGM on the market, sending real-time glucose readings automatically to a compatible smart device§ or receiver, with no painful finger sticks† or scanning required.
Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C and reduce hyper- and hypoglycemia.
1.Its customizable alerts can warn of high or low glucose levels and help users spend more time in range.
2. Industry-leading remote monitoring and reporting capabilities also allow users to stay connected with their loved ones and care teams anytime, anywhere.
New features with Dexcom G7:
• 60 percent smaller, all-in-one, discreet wearable, developed in partnership with Verily
• 30-minute sensor warm up, fastest of any CGM on the market
• 12-hour grace period to replace finished sensors for a more seamless transition between sessions
• Redesigned and simplified mobile app with Dexcom Clarity integration
• Improved alert settings for enhanced discretion
• Redesigned optional receiver that is smaller, with a more vibrant, easier to read display
• Direct to Apple Watch (anticipated future software release)
Dexcom G6 features included with Dexcom G7:
• No finger sticks, scanning or calibration
• Real-time glucose readings sent automatically to a compatible display devices
• Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old
• Remote monitoring, enabling users to share glucose data with up to 10 followers
• Proven Dexcom accuracy and performance3
Dexcom is also working closely with its insulin pump partners to integrate Dexcom G7 into current and future
automated insulin delivery systems as quickly as possible.
Article Submitted: African Communications Group
